Figure 1.

Mechanotransduction in liver resident cells.

Cell 1. ECM-mediated mechanical forces induce activation of integrin and the formation of FAs comprised of actin-binding proteins, such as talin and vinculin, and signaling molecules, such as FAK, Src, PI3K and so on. Through a direct force transfer to the actin filaments and RhoA-mediated biochemical signaling, external forces are translated into actomyosin contractility, cytoskeleton remodeling, and gene transcription, culminating in a new phenotype of the cell.

Cell 2. Forces on E-cadherin induce the formation of cadherin complexes, which transmit forces into the interior of the cell by the actin filaments and signaling molecule such as RhoA. E-cadherin-mediated signaling is essential for the development of contact inhibition of cell proliferation of epithelial cells.

Cell 3. In HSCs, ECM-mediated forces or stretch of the plasma membrane activate integrin and its downstream signals leading to nuclear translocation of YAP1, p300 or MRTF, which subsequently turns on gene transcription for HSC activation. In addition, LSEC-dependent angiogenesis at the early-stage of fibrosis leads to ECM remodeling and mechanical forces that promote HSC activation by a collagen-DDR2/JAK2/PI3K/AKT mechanosignaling.

Cell 4. Shear stress induces the formation of a mechanosensory protein complex comprised of PECAM-1, VE-cadherin, and VEGFR2. In this complex, VE-cadherin functions as an adaptor and PECAM-1 activates Src and binds to the intermediate vimentin filaments for force transmission. VEGFR2 activates PI3K, which leads to subsequent integrin activation and the biological responses, such as cell alignment in laminar shear and activation of NF-κB. In addition, shear stress-induced mechanosignaling leads to the release of hepatic growth factor (HGF) that triggers the proliferation and survival of adjacent hepatocytes.

Cell 5. Mechanical stretch of the cell membrane of LSECs activates cation channels. In addition, pulsatile forces on LSECs, as a result of hepatic congestion, activate integrin/Piezo/Notch to induce the release of CXCL1 that participates in the pathogenesis of portal hypertension.